Compare ESQ & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESQ | FLGT |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.2M | 697.3M |
| IPO Year | 2017 | 2016 |
| Metric | ESQ | FLGT |
|---|---|---|
| Price | $106.30 | $26.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $113.00 | $28.33 |
| AVG Volume (30 Days) | 72.0K | ★ 272.3K |
| Earning Date | 01-22-2026 | 11-07-2025 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | ★ 14.70 | N/A |
| EPS | ★ 5.68 | N/A |
| Revenue | $131,743,000.00 | ★ $315,549,000.00 |
| Revenue This Year | N/A | $16.84 |
| Revenue Next Year | $18.55 | $9.74 |
| P/E Ratio | $18.88 | ★ N/A |
| Revenue Growth | 13.37 | ★ 13.61 |
| 52 Week Low | $68.90 | $14.57 |
| 52 Week High | $108.55 | $31.04 |
| Indicator | ESQ | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 64.21 | 45.89 |
| Support Level | $100.63 | $26.69 |
| Resistance Level | $108.55 | $31.04 |
| Average True Range (ATR) | 2.88 | 0.74 |
| MACD | 0.48 | -0.44 |
| Stochastic Oscillator | 78.68 | 9.29 |
Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.